<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2007-01-23" modified="2020-10-07" version="149">
<accession>Q96RE7</accession>
<name>NACC1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Nucleus accumbens-associated protein 1</fullName>
<shortName>NAC-1</shortName>
</recommendedName>
<alternativeName>
<fullName>BTB/POZ domain-containing protein 14B</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NACC1</name>
<name type="synonym">BTBD14B</name>
<name type="synonym">NAC1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2001-06" db="EMBL/GenBank/DDBJ databases">
<title>Human NAC1 protein, a gene transcriptional repressor.</title>
<authorList>
<person name="Cha X.Y."/>
<person name="Fakharzadeh S.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Keratinocyte</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Eye</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="18739" last="18744">
<title>A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival.</title>
<authorList>
<person name="Nakayama K."/>
<person name="Nakayama N."/>
<person name="Davidson B."/>
<person name="Sheu J.-J.C."/>
<person name="Jinawath N."/>
<person name="Santillan A."/>
<person name="Salani R."/>
<person name="Bristow R.E."/>
<person name="Morin P.J."/>
<person name="Kurman R.J."/>
<person name="Wang T.-L."/>
<person name="Shih I.-M."/>
</authorList>
<dbReference type="PubMed" id="17130457"/>
<dbReference type="DOI" id="10.1073/pnas.0604083103"/>
</citation>
<scope>FUNCTION</scope>
<scope>HOMOOLIGOMERIZATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="8058" last="8064">
<title>NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor.</title>
<authorList>
<person name="Nakayama K."/>
<person name="Nakayama N."/>
<person name="Wang T.-L."/>
<person name="Shih I.-M."/>
</authorList>
<dbReference type="PubMed" id="17804717"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-07-1357"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="Hum. Pathol." volume="38" first="1030" last="1036">
<title>Expression and clinical role of the bric-a-brac tramtrack broad complex/poxvirus and zinc protein NAC-1 in ovarian carcinoma effusions.</title>
<authorList>
<person name="Davidson B."/>
<person name="Berner A."/>
<person name="Trope' C.G."/>
<person name="Wang T.-L."/>
<person name="Shih I.-M."/>
</authorList>
<dbReference type="PubMed" id="17391728"/>
<dbReference type="DOI" id="10.1016/j.humpath.2006.12.009"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-167 AND LYS-483</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-167</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-167 AND LYS-483</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-167 AND LYS-483</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2017" name="Am. J. Hum. Genet." volume="100" first="343" last="351">
<title>A recurrent de novo variant in NACC1 causes a syndrome characterized by infantile epilepsy, cataracts, and profound developmental delay.</title>
<authorList>
<consortium name="UCLA Clinical Genomics Center"/>
<consortium name="Undiagnosed Diseases Network"/>
<person name="Schoch K."/>
<person name="Meng L."/>
<person name="Szelinger S."/>
<person name="Bearden D.R."/>
<person name="Stray-Pedersen A."/>
<person name="Busk O.L."/>
<person name="Stong N."/>
<person name="Liston E."/>
<person name="Cohn R.D."/>
<person name="Scaglia F."/>
<person name="Rosenfeld J.A."/>
<person name="Tarpinian J."/>
<person name="Skraban C.M."/>
<person name="Deardorff M.A."/>
<person name="Friedman J.N."/>
<person name="Akdemir Z.C."/>
<person name="Walley N."/>
<person name="Mikati M.A."/>
<person name="Kranz P.G."/>
<person name="Jasien J."/>
<person name="McConkie-Rosell A."/>
<person name="McDonald M."/>
<person name="Wechsler S.B."/>
<person name="Freemark M."/>
<person name="Kansagra S."/>
<person name="Freedman S."/>
<person name="Bali D."/>
<person name="Millan F."/>
<person name="Bale S."/>
<person name="Nelson S.F."/>
<person name="Lee H."/>
<person name="Dorrani N."/>
<person name="Goldstein D.B."/>
<person name="Xiao R."/>
<person name="Yang Y."/>
<person name="Posey J.E."/>
<person name="Martinez-Agosto J.A."/>
<person name="Lupski J.R."/>
<person name="Wangler M.F."/>
<person name="Shashi V."/>
</authorList>
<dbReference type="PubMed" id="28132692"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2016.12.013"/>
</citation>
<scope>INVOLVEMENT IN NECFM</scope>
<scope>VARIANT NECFM TRP-298</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-167; LYS-183; LYS-318; LYS-452; LYS-480; LYS-483 AND LYS-498</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Acta Crystallogr. F" volume="65" first="445" last="449">
<title>Structure of the human Nac1 POZ domain.</title>
<authorList>
<person name="Stead M.A."/>
<person name="Carr S.B."/>
<person name="Wright S.C."/>
</authorList>
<dbReference type="PubMed" id="19407373"/>
<dbReference type="DOI" id="10.1107/s1744309109012214"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 2-125</scope>
</reference>
<comment type="function">
<text evidence="13 15">Functions as a transcriptional repressor. Seems to function as a transcriptional corepressor in neuronal cells through recruitment of HDAC3 and HDAC4. Contributes to tumor progression, and tumor cell proliferation and survival. This may be mediated at least in part through repressing transcriptional activity of GADD45GIP1. Required for recruiting the proteasome from the nucleus to the cytoplasm and dendritic spines.</text>
</comment>
<comment type="subunit">
<text>Homooligomer; mediated by the BTB domain. Interacts with HDAC3 and HDAC4. Interacts (via BTB domain) with CUL3, PSMD7 AND RCOR1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7950997">
<id>Q96RE7</id>
</interactant>
<interactant intactId="EBI-715389">
<id>Q9H7E9</id>
<label>C8orf33</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7950997">
<id>Q96RE7</id>
</interactant>
<interactant intactId="EBI-2339219">
<id>Q08426</id>
<label>EHHADH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7950997">
<id>Q96RE7</id>
</interactant>
<interactant intactId="EBI-742350">
<id>Q14241</id>
<label>ELOA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7950997">
<id>Q96RE7</id>
</interactant>
<interactant intactId="EBI-12069522">
<id>O00214-2</id>
<label>LGALS8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7950997">
<id>Q96RE7</id>
</interactant>
<interactant intactId="EBI-348239">
<id>P62310</id>
<label>LSM3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7950997">
<id>Q96RE7</id>
</interactant>
<interactant intactId="EBI-359527">
<id>P62875</id>
<label>POLR2L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7950997">
<id>Q96RE7</id>
</interactant>
<interactant intactId="EBI-286199">
<id>P41743</id>
<label>PRKCI</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7950997">
<id>Q96RE7</id>
</interactant>
<interactant intactId="EBI-2798416">
<id>Q99633</id>
<label>PRPF18</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7950997">
<id>Q96RE7</id>
</interactant>
<interactant intactId="EBI-744322">
<id>O43395</id>
<label>PRPF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7950997">
<id>Q96RE7</id>
</interactant>
<interactant intactId="EBI-17208936">
<id>P0CB47</id>
<label>UBTFL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7950997">
<id>Q96RE7</id>
</interactant>
<interactant intactId="EBI-1049952">
<id>Q96KM6</id>
<label>ZNF512B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text evidence="9">Distribution in the cytoplasm is dependent on phosphorylation.</text>
</comment>
<comment type="tissue specificity">
<text evidence="13 14">Overexpressed in several types of carcinomas including ovarian serous carcinomas. Expression levels positively correlate with tumor recurrence in ovarian serous carcinomas, and intense immunoreactivity in primary ovarian tumors predicts early recurrence. Up-regulated in ovarian carcinomas after chemotherapy, suggesting a role in development of chemotherapy resistance in ovarian cancer.</text>
</comment>
<comment type="disease" evidence="16">
<disease id="DI-04969">
<name>Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination</name>
<acronym>NECFM</acronym>
<description>A neurodevelopmental disorder characterized by microcephaly, profound developmental delay, intellectual disability, cataracts, severe epilepsy including infantile spasms, irritability, failure to thrive, and stereotypic hand movements. Brain imaging reveals delayed myelination and cerebral atrophy.</description>
<dbReference type="MIM" id="617393"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/NACC1ID44511ch19p13.html"/>
</comment>
<comment type="online information" name="Undiagnosed Disease Network">
<link uri="https://undiagnosed.hms.harvard.edu/updates/genes-of-interest/nacc1-gene/"/>
<text>NACC1</text>
</comment>
<dbReference type="EMBL" id="AF395817">
<property type="protein sequence ID" value="AAK83885.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC055396">
<property type="protein sequence ID" value="AAH55396.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12294.1"/>
<dbReference type="RefSeq" id="NP_443108.1">
<property type="nucleotide sequence ID" value="NM_052876.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005259778.1">
<property type="nucleotide sequence ID" value="XM_005259721.3"/>
</dbReference>
<dbReference type="PDB" id="3GA1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=2-125"/>
</dbReference>
<dbReference type="PDB" id="4U2N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=2-125"/>
</dbReference>
<dbReference type="PDBsum" id="3GA1"/>
<dbReference type="PDBsum" id="4U2N"/>
<dbReference type="SMR" id="Q96RE7"/>
<dbReference type="BioGRID" id="125217">
<property type="interactions" value="54"/>
</dbReference>
<dbReference type="IntAct" id="Q96RE7">
<property type="interactions" value="27"/>
</dbReference>
<dbReference type="MINT" id="Q96RE7"/>
<dbReference type="STRING" id="9606.ENSP00000292431"/>
<dbReference type="iPTMnet" id="Q96RE7"/>
<dbReference type="MetOSite" id="Q96RE7"/>
<dbReference type="PhosphoSitePlus" id="Q96RE7"/>
<dbReference type="SwissPalm" id="Q96RE7"/>
<dbReference type="BioMuta" id="NACC1"/>
<dbReference type="DMDM" id="74732694"/>
<dbReference type="EPD" id="Q96RE7"/>
<dbReference type="jPOST" id="Q96RE7"/>
<dbReference type="MassIVE" id="Q96RE7"/>
<dbReference type="MaxQB" id="Q96RE7"/>
<dbReference type="PaxDb" id="Q96RE7"/>
<dbReference type="PeptideAtlas" id="Q96RE7"/>
<dbReference type="PRIDE" id="Q96RE7"/>
<dbReference type="ProteomicsDB" id="77953"/>
<dbReference type="Antibodypedia" id="13525">
<property type="antibodies" value="291 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000292431">
<property type="protein sequence ID" value="ENSP00000292431"/>
<property type="gene ID" value="ENSG00000160877"/>
</dbReference>
<dbReference type="GeneID" id="112939"/>
<dbReference type="KEGG" id="hsa:112939"/>
<dbReference type="UCSC" id="uc002mwm.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="112939"/>
<dbReference type="DisGeNET" id="112939"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000160877.5"/>
<dbReference type="GeneCards" id="NACC1"/>
<dbReference type="HGNC" id="HGNC:20967">
<property type="gene designation" value="NACC1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000160877">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="NACC1"/>
<dbReference type="MIM" id="610672">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617393">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96RE7"/>
<dbReference type="OpenTargets" id="ENSG00000160877"/>
<dbReference type="Orphanet" id="500545">
<property type="disease" value="Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract"/>
</dbReference>
<dbReference type="PharmGKB" id="PA164723404"/>
<dbReference type="eggNOG" id="KOG1721">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159327"/>
<dbReference type="HOGENOM" id="CLU_029038_1_0_1"/>
<dbReference type="InParanoid" id="Q96RE7"/>
<dbReference type="KO" id="K10486"/>
<dbReference type="OMA" id="QFLLIYT"/>
<dbReference type="OrthoDB" id="567120at2759"/>
<dbReference type="PhylomeDB" id="Q96RE7"/>
<dbReference type="TreeFam" id="TF331184"/>
<dbReference type="PathwayCommons" id="Q96RE7"/>
<dbReference type="SIGNOR" id="Q96RE7"/>
<dbReference type="BioGRID-ORCS" id="112939">
<property type="hits" value="19 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="NACC1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q96RE7"/>
<dbReference type="GeneWiki" id="BTBD14B"/>
<dbReference type="GenomeRNAi" id="112939"/>
<dbReference type="Pharos" id="Q96RE7">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q96RE7"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="Q96RE7">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000160877">
<property type="expression patterns" value="Expressed in cerebellum and 221 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q96RE7">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q96RE7">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030054">
<property type="term" value="C:cell junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="InterPro" id="IPR018379">
<property type="entry name" value="BEN_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR000210">
<property type="entry name" value="BTB/POZ_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011333">
<property type="entry name" value="SKP1/BTB/POZ_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF10523">
<property type="entry name" value="BEN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00651">
<property type="entry name" value="BTB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01025">
<property type="entry name" value="BEN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00225">
<property type="entry name" value="BTB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54695">
<property type="entry name" value="SSF54695"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51457">
<property type="entry name" value="BEN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50097">
<property type="entry name" value="BTB"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Nucleus accumbens-associated protein 1" id="PRO_0000274041">
<location>
<begin position="1"/>
<end position="527"/>
</location>
</feature>
<feature type="domain" description="BTB" evidence="11">
<location>
<begin position="30"/>
<end position="94"/>
</location>
</feature>
<feature type="domain" description="BEN" evidence="12">
<location>
<begin position="374"/>
<end position="471"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="194"/>
<end position="199"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="188"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC" evidence="10">
<location>
<position position="259"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="4">
<location>
<position position="167"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="4 5 6 7 8">
<location>
<position position="167"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="183"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="318"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="452"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="480"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5 6 7 8">
<location>
<position position="483"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="498"/>
</location>
</feature>
<feature type="sequence variant" description="In NECFM; dbSNP:rs1060505041." id="VAR_078808" evidence="16">
<original>R</original>
<variation>W</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4"/>
<end position="8"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="12"/>
<end position="25"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="26"/>
<end position="29"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="32"/>
<end position="36"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="39"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="45"/>
<end position="51"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="53"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="65"/>
<end position="68"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="75"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="88"/>
<end position="91"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="94"/>
<end position="96"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="97"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="110"/>
<end position="113"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GA1"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4U2N"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250"/>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O35260"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00037"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00784"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17130457"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17391728"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17804717"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28132692"/>
</source>
</evidence>
<sequence length="527" mass="57258" checksum="00BEA89D2DC3DAD2" modified="2001-12-01" version="1">MAQTLQMEIPNFGNSILECLNEQRLQGLYCDVSVVVKGHAFKAHRAVLAASSSYFRDLFNNSRSAVVELPAAVQPQSFQQILSFCYTGRLSMNVGDQFLLMYTAGFLQIQEIMEKGTEFFLKVSSPSCDSQGLHAEEAPSSEPQSPVAQTSGWPACSTPLPLVSRVKTEQQESDSVQCMPVAKRLWDSGQKEAGGGGNGSRKMAKFSTPDLAANRPHQPPPPQQAPVVAAAQPAVAAGAGQPAGGVAAAGGVVSGPSTSERTSPGTSSAYTSDSPGSYHNEEDEEEDGGEEGMDEQYRQICNMYTMYSMMNVGQTAEKVEALPEQVAPESRNRIRVRQDLASLPAELINQIGNRCHPKLYDEGDPSEKLELVTGTNVYITRAQLMNCHVSAGTRHKVLLRRLLASFFDRNTLANSCGTGIRSSTNDPRRKPLDSRVLHAVKYYCQNFAPNFKESEMNAIAADMCTNARRVVRKSWMPKVKVLKAEDDAYTTFISETGKIEPDMMGVEHGFETASHEGEAGPSAEALQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

